Corrigendum to: Factors driving the use of dermoscopy in Europe: a pan-European survey (British Journal of Dermatology, (2016), 175, 6, (1329-1337), 10.1111/bjd.14895);Factors driving the use of dermoscopy in Europe: a pan-European survey

British Journal of Dermatology

Volumn 175, Issue 6, 2016, Pages 1329-1337

  Forsea, A M ^a   Tschand, P ^a,b   del Marmo, V ^a,c   Zalaudek, I ^d   Soyer, H P ^e   Arenbergerova, M ^f   Azenha, A ^g   Blum, A ^h   Bowling, J C ⁱ   Braun, R P ^j   Bylaite Bucinskiene, M ^k   Cabrijan, L ^l   Dobrev, H ^m   Hegy, J ⁿ   Helppikangas, H ^o   Hofmann Wellenhof, R ^d   Karls, R ^p   Krumkachou, U ^q   Kukutsch, N ^r   McCormack, I ^s   Mekokishvili, L ^t   Nathansohn, N ^u   Nielsen, K ^v   Olah, J ^w   Ozdemir, F ^x   Puig, S ^y,z,aa   Rubegni, P ^ab   Rucigaj, T Planinsek ^ac   Schopf, T R ^ad   Sergeev, V ^ae   Stratigos, A ^af   Thomas, L ^ag,ah,ai   Tiodorovic, D ^aj   Vahlberg, A ^ak   Zafirovik, Z ^al   Geller, A C ^am   Argenziano, G ^an   more..

^a CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b Universitatsklinik fur Dermatologie   (Austria)

^c ERASME HOSPITAL   (Belgium)

^d MEDICAL UNIVERSITY OF GRAZ   (Austria)

^e UNIVERSITY OF QUEENSLAND   (Australia)

^f CHARLES UNIVERSITY   (Czech Republic)

^g Hospital Privado da Trofa   (Portugal)

^h Private and Teaching Practice of Dermatology   (Germany)

ⁱ Nuffield   (United Kingdom)

^j UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^k VILNIUS UNIVERSITY   (Lithuania)

^l KBC RIJEKA   (Croatia)

^m MEDICAL UNIVERSITY OF PLOVDIV   (Bulgaria)

ⁿ Institute of Experimental and Clinical Medicine   (Slovakia)

^o UNIVERSITY OF SARAJEVO   (Bosnia and Herzegovina)

^p RIGA STRADINS UNIVERSITY   (Latvia)

^q BELARUSIAN MEDICAL ACADEMY OF POSTGRADUATE EDUCATION   (Belarus)

^r LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^s ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

^t Rehabilitation and Medicinal Tourism of Georgia   (Georgia)

^u SHEBA MEDICAL CENTER   (Israel)

^v LUND UNIVERSITY   (Sweden)

^w UNIVERSITY OF SZEGED   (Hungary)

^x EGE UNIVERSITY   (Turkey)

^y INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^z INSTITUTO DE SALUD CARLOS III   (Spain)

^aa UNIVERSITY OF BARCELONA   (Spain)

^ab UNIVERSITY OF SIENA   (Italy)

^ac UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^ad UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^ae Central Research Dermatology Clinic Dmitrovskoe   (Russian Federation)

^af UNIVERSITY OF ATHENS   (Greece)

^ag UNIVERSITÉ LYON 1   (France)

^ah CENTRE HOSPITALIER LYON SUD   (France)

^ai CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

^aj Department of Experimental Pharmacology   (Serbia)

^ak Vahlberg Pild Ltd   (Estonia)

^al SS CYRIL AND METHODIUS UNIVERSITY OF SKOPJE   (Macedonia)

^am HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^an SECOND UNIVERSITY OF NAPLES   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CLINICAL PRACTICE; DEMOGRAPHY; DERMATOLOGIST; DERMATOLOGY; EPILUMINESCENCE MICROSCOPY; EUROPE; FEMALE; HUMAN; MALE; MOTIVATION; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; RESIDENCY EDUCATION; SEX DIFFERENCE; SKILL; SKIN DISEASE; STAFF TRAINING; TOOL USE; VERY ELDERLY; ATTITUDE TO HEALTH; CLINICAL TRIAL; DIAGNOSTIC IMAGING; HEALTH PERSONNEL ATTITUDE; MIDDLE AGED; MULTICENTER STUDY; PSYCHOLOGY; UTILIZATION;

ADULT; ATTITUDE OF HEALTH PERSONNEL; ATTITUDE TO HEALTH; DERMATOLOGISTS; DERMOSCOPY; EUROPE; FEMALE; HUMANS; MALE; MIDDLE AGED; SKIN DISEASES;

EID: 85000415166     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.15295     Document Type: Erratum

References (44)

1. Argenziano G, Albertini G, Castagnetti F et al. Early diagnosis of melanoma: what is the impact of dermoscopy? Dermatol Ther 2012; 25:403–9.
2. Argenziano G, Giacomel J, Zalaudek I et al. A clinico-dermoscopic approach for skin cancer screening: recommendations involving a survey of the International Dermoscopy Society. Dermatol Clin 2013; 31:525–34, vii.
3. Breton AL, Amini-Adle M, Duru G et al. Overview of the use of dermoscopy in academic and non-academic hospital centres in France: a nationwide survey. J Eur Acad Dermatol Venereol 2014; 28:1207–13.
4. Butler TD, Matin RN, Affleck AG et al. Trends in dermoscopy use in the UK: results from surveys in 2003 and 2012. Dermatol Pract Concept 2015; 5:29–38.
5. Moulin C, Poulalhon N, Duru G et al. Dermoscopy use by French private practice dermatologists: a nationwide survey. Br J Dermatol 2013; 168:74–9.
6. Piliouras P, Buettner P, Soyer HP. Dermoscopy use in the next generation: a survey of Australian dermatology trainees. Australas J Dermatol 2014; 55:49–52.
7. Venugopal SS, Soyer HP, Menzies SW. Results of a nationwide dermoscopy survey investigating the prevalence, advantages and disadvantages of dermoscopy use among Australian dermatologists. Australas J Dermatol 2011; 52:14–18.
8. Engasser HC, Warshaw EM. Dermatoscopy use by US dermatologists: a cross-sectional survey. J Am Acad Dermatol 2010; 63:412–19, 419.e1–2.
9. Murzaku EC, Hayan S, Rao BK. Methods and rates of dermoscopy usage: a cross-sectional survey of US dermatologists stratified by years in practice. J Am Acad Dermatol 2014; 71:393–5.
10. Noor O 2nd, Nanda A, Rao BK. A dermoscopy survey to assess who is using it and why it is or is not being used. Int J Dermatol 2009; 48:951–2.
11. Terushkin V, Oliveria SA, Marghoob AA, Halpern AC. Use of and beliefs about total body photography and dermatoscopy among US dermatology training programs: an update. J Am Acad Dermatol 2010; 62:794–803.
12. Forsea AM, Del Marmol V, de Vries E et al. Melanoma incidence and mortality in Europe: new estimates, persistent disparities. Br J Dermatol 2012; 167:1124–30.
13. Arnold M, Holterhues C, Hollestein LM et al. Trends in incidence and predictions of cutaneous melanoma across Europe up to 2015. J Eur Acad Dermatol Venereol 2014; 28:1170–8.
14. Barbaric J, Sekerija M, Agius D et al. Disparities in melanoma incidence and mortality in South-Eastern Europe: increasing incidence and divergent mortality patterns. Is progress around the corner? Eur J Cancer 2016; 55:47–55.
15. De Angelis R, Sant M, Coleman MP et al. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5–a population-based study. Lancet Oncol 2014; 15:23–34.
16. de Vries E, Coebergh JW. Cutaneous malignant melanoma in Europe. Eur J Cancer 2004; 40:2355–66.
17. Argenziano G, Cerroni L, Zalaudek I et al. Accuracy in melanoma detection: a 10-year multicenter survey. J Am Acad Dermatol 2012; 67:54–9.
18. Kittler H, Pehamberger H, Wolff K, Binder M. Diagnostic accuracy of dermoscopy. Lancet Oncol 2002; 3:159–65.
19. Liebman TN, Goulart JM, Soriano R et al. Effect of dermoscopy education on the ability of medical students to detect skin cancer. Arch Dermatol 2012; 148:1016–22.
20. Tromme I, Devleesschauwer B, Beutels P et al. Selective use of sequential digital dermoscopy imaging allows a cost reduction in the melanoma detection process: a Belgian study of patients with a single or a small number of atypical nevi. PLoS ONE 2014; 9:e109339.
21. Tromme I, Sacré L, Hammouch F et al. Availability of digital dermoscopy in daily practice dramatically reduces the number of excised melanocytic lesions: results from an observational study. Br J Dermatol 2012; 167:778–86.
22. van der Rhee JI, Bergman W, Kukutsch NA. The impact of dermoscopy on the management of pigmented lesions in everyday clinical practice of general dermatologists: a prospective study. Br J Dermatol 2010; 162:563–7.
23. Vestergaard ME, Macaskill P, Holt PE, Menzies SW. Dermoscopy compared with naked eye examination for the diagnosis of primary melanoma: a meta-analysis of studies performed in a clinical setting. Br J Dermatol 2008; 159:669–76.
24. Zalaudek I, Kreusch J, Giacomel J et al. How to diagnose nonpigmented skin tumors: a review of vascular structures seen with dermoscopy: part II. Nonmelanocytic skin tumors. J Am Acad Dermatol 2010; 63:377–86; quiz 87–8.
25. Zalaudek I, Kreusch J, Giacomel J et al. How to diagnose nonpigmented skin tumors: a review of vascular structures seen with dermoscopy: part I. Melanocytic skin tumors. J Am Acad Dermatol 2010; 63:361–74.
26. Giacomel J, Zalaudek I, Argenziano G, Lallas A. Dermoscopy of hypertrophic lupus erythematosus and differentiation from squamous cell carcinoma. J Am Acad Dermatol 2015; 72(1 Suppl.):S33–6.
27. Errichetti E, Stinco G. The practical usefulness of dermoscopy in general dermatology. G Ital Dermatol Venereol 2015; 150:533–46.
28. Goncharova Y, Attia EA, Souid K et al. Dermoscopic features of clinically inflammatory dermatoses and their correlation with histopathologic reaction patterns. Arch Dermatol Res 2015; 307:23–30.
29. Garbe C, Peris K, Hauschild A et al. Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline–update 2012. Eur J Cancer 2012; 48:2375–90.
30. Pflugfelder A, Kochs C, Blum A et al. Malignant melanoma S3-guideline ‘diagnosis, therapy and follow-up of melanoma’. J Dtsch Dermatol Ges 2013; 11(Suppl. 6):1–116, 1–26.
31. Watts CG, Dieng M, Morton RL et al. Clinical practice guidelines for identification, screening and follow-up of individuals at high risk of primary cutaneous melanoma: a systematic review. Br J Dermatol 2015; 172:33–47.
32. Marsden JR, Newton-Bishop JA, Burrows L et al. Revised U.K. guidelines for the management of cutaneous melanoma 2010. Br J Dermatol 2010; 163:238–56.
33. United Nations Statistics Division. Composition of macro geographical (continental) regions, geographical sub-regions, and selected economic and other groupings. Available at http://unstats.un.org/unsd/methods/m49/m49regin.htm#europe (last accessed 27 September 2016).
34. Stratigos AJ, Forsea AM, van der Leest RJ et al. Euromelanoma: a dermatology-led European campaign against nonmelanoma skin cancer and cutaneous melanoma. Past, present and future. Br J Dermatol 2012; 167(Suppl. 2):99–104.
35. Council of Europe. 47 Member States. Available at: http://www.coe.int/en/web/portal/47-members-states (last accessed on 27 September 2016).
36. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat 1979; 6:65–70.
37. Wickham H. ggplot2: Elegant Graphics for Data Analysis. New York: Springer-Verlag, 2009.
38. Argenziano G, Soyer HP, Chimenti S et al. Dermoscopy of pigmented skin lesions: results of a consensus meeting via the Internet. J Am Acad Dermatol 2003; 48:679–93.
39. di Meo N, Stinco G, Bonin S et al. CASH algorithm versus 3-point checklist and its modified version in evaluation of melanocytic pigmented skin lesions: the 4-point checklist. J Dermatol 2016; 43:682–5.
40. Scope A, Braun RP. The recognition process in dermoscopy: analytic approach vs heuristic approach. JAMA Dermatol 2015; 151:704–6.
41. Moloney FJ, Guitera P, Coates E et al. Detection of primary melanoma in individuals at extreme high risk: a prospective 5-year follow-up study. JAMA Dermatol 2014; 150:819–27.
42. Moscarella E, Pampena R, Kyrgidis A et al. Digital dermoscopy monitoring in patients with multiple nevi: How many lesions should we monitor per patient? J Am Acad Dermatol 2015; 73:168–70.
43. Leachman SA, Cassidy PB, Chen SC et al. Methods of melanoma detection. Cancer Treat Res 2016; 167:51–105.
44. Koelink CJ, Vermeulen KM, Kollen BJ et al. Diagnostic accuracy and cost-effectiveness of dermoscopy in primary care: a cluster randomized clinical trial. J Eur Acad Dermatol Venereol 2014; 28:1442–9.